October 17, 2012
Bernstein Liebhard LLP is investigating whether the Board of Directors of Cymer, Inc. (“Cymer” or the “Company”) (NASDAQ: CYMI) breached its fiduciary duty to its shareholders in agreeing to sell Cymer to ASML Holding NV (NASDAQ: ASML).
Under the terms of the agreement, Cymer shareholders will receive $20.00 in cash and a fixed ratio of 1.1502 ASML ordinary shares for each share they own. The investigation is focused on the potential unfairness of the price to Cymer shareholders and the process by which the Cymer Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a Cymer stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at: (877) 779-1414 or Ottensoser@bernlieb.com.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last ten years.
